Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis ; volume:9 ; number:1 ; day:1 ; month:3 ; year:2019 ; pages:1-15 ; date:12.2019
Scientific reports ; 9, Heft 1 (1.3.2019), 1-15, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Schau, Isabell
Michen, Susanne
Hagstotz, Alexander
Janke, Andreas
Schackert, Gabriele
Appelhans, Dietmar
Temme, Achim
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-40032-8
- URN
-
urn:nbn:de:101:1-2019032321261869549052
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schau, Isabell
- Michen, Susanne
- Hagstotz, Alexander
- Janke, Andreas
- Schackert, Gabriele
- Appelhans, Dietmar
- Temme, Achim
- SpringerLink (Online service)
Ähnliche Objekte (12)
Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
Anti-Fn14 antibody-conjugated nanoparticles display membrane TWEAK-like agonism
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus‐specific neutralizing antibody response
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
In vitro assessment of antibody-conjugated gold nanorods for systemic injections
Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
Anti-Fn14 antibody-conjugated nanoparticles display membrane TWEAK-like agonism
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus‐specific neutralizing antibody response
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
In vitro assessment of antibody-conjugated gold nanorods for systemic injections
Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
Anti-Fn14 antibody-conjugated nanoparticles display membrane TWEAK-like agonism
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus‐specific neutralizing antibody response
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone